{"id":1832,"date":"2013-05-08T13:49:09","date_gmt":"2013-05-08T13:49:09","guid":{"rendered":"https:\/\/www.lymphoma.ca\/le-prix-fort-dun-traitement-innovant\/"},"modified":"2013-05-08T13:49:09","modified_gmt":"2013-05-08T13:49:09","slug":"le-prix-fort-dun-traitement-innovant","status":"publish","type":"post","link":"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/","title":{"rendered":"Le prix fort d\u2019un traitement innovant"},"content":{"rendered":"

En f\u00e9vrier dernier, Sant\u00e9 Canada a autoris\u00e9 la vente d\u2019ADCETRIS,
\n<\/p>\n

Les remarquables propri\u00e9t\u00e9s anticanc\u00e9reuses d\u2019ADCETRIS ont un prix, et un gros <\/strong><\/h2>\n

En f\u00e9vrier dernier, Sant\u00e9 Canada a autoris\u00e9 la vente d\u2019ADCETRIS, un m\u00e9dicament innovant. Malheureusement, les patients atteints du lymphome de Hodgkin ne peuvent pas tous b\u00e9n\u00e9ficier de ses propri\u00e9t\u00e9s anticanc\u00e9reuses, puisque le m\u00e9dicament n\u2019est pas encore officiellement couvert<\/strong> dans toutes les provinces.<\/p>\n

Dre<\/sup> Bence-Bruckler est h\u00e9matooncologue et professeure agr\u00e9\u00e9e \u00e0 la facult\u00e9 de m\u00e9decine de l\u2019H\u00f4pital g\u00e9n\u00e9ral d\u2019Ottawa. \u00ab C\u2019est tr\u00e8s frustrant [\u2026] de savoir qu\u2019il existe un traitement qui prolongerait potentiellement une vie, mais qu\u2019il n\u2019est pas couvert partout. \u00bb<\/p>\n

Le co\u00fbt total du traitement s\u2019\u00e9l\u00e8ve \u00e0 environ 100 000 $, mais la plupart des assureurs priv\u00e9s ne le couvrent pas, arguant que le m\u00e9dicament devrait \u00eatre subventionn\u00e9 par l\u2019\u00c9tat.<\/strong><\/p>\n

Quoi qu\u2019il en soit, ce m\u00e9dicament est innovant en ceci qu\u2019il contient un anticorps qui peut d\u00e9truire sp\u00e9cifiquement les cellules canc\u00e9reuses (cellules d\u2019expression de CD30). \u00ab La chimioth\u00e9rapie, pour sa part [\u2026] cible diverses cellules du corps, ce qui explique que les gens perdent leurs cheveux, souffrent d\u2019infertilit\u00e9 ou de maladies auto-immunes \u00bb.<\/p>\n

ADCETRIS a re\u00e7u une approbation de mise en march\u00e9 acc\u00e9l\u00e9r\u00e9e en ao\u00fbt 2011, de la FDA aux \u00c9tats-Unis (Food and Drug Administration), et a obtenu une approbation conditionnelle de mise en march\u00e9 de la Commission europ\u00e9enne en octobre 2012. <\/p>\n

Il a \u00e9t\u00e9 autoris\u00e9 en se fondant sur les taux de r\u00e9ponse prometteurs r\u00e9v\u00e9l\u00e9s dans le cadre d’essais sur un seul groupe. Toutefois, plusieurs patients attendent toujours la d\u00e9cision au sujet du financement. \u00ab Il y a d\u00e9calage<\/strong> entre l\u2019approbation d\u2019un m\u00e9dicament par Sant\u00e9 Canada et le financement par certaines provinces, qui fonctionnent au cas par cas<\/strong> \u00bb, explique Sue Robson, directrice administrative de Lymphome Canada.<\/p>\n

La recherche de nouveaux m\u00e9dicaments commence lorsque les chercheurs travaillent au d\u00e9veloppement de substances chimiques ou biologiques. Selon Sant\u00e9 Canada, la nouvelle substance est examin\u00e9e par le personnel scientifique de la Direction des produits th\u00e9rapeutiques (DPT). \u00c0 la suite de nombreux tests et la validation des hypoth\u00e8ses sur les cultures tissulaires ou les petits animaux, une compagnie effectue une demande d\u2019autorisation aupr\u00e8s de la DPT, afin de mener une \u00e9tude clinique. Si les essais cliniques r\u00e9v\u00e8lent que la valeur m\u00e9dicale du m\u00e9dicament l\u2019emporte sur les risques que comporte son utilisation, la compagnie pourra d\u00e9cider de soumettre une Pr\u00e9sentation de drogue nouvelle \u00e0 la DPT.<\/p>\n

\u00ab Le processus est tr\u00e8s long \u00bb, admet Bence-Bruckler.<\/p>\n

Une fois la pr\u00e9sentation \u00e9valu\u00e9e, Sant\u00e9 Canada d\u00e9cidera si le m\u00e9dicament recevra ou non son autorisation. Chaque province \u00e9value ensuite si le m\u00e9dicament sera subventionn\u00e9 ou pas. Lymphome Canada, en collaboration avec de nombreux partenaires communautaires, tente de faire valoir l\u2019impact qu\u2019aurait ce m\u00e9dicament sur l\u2019ensemble des patients canadiens atteints de la maladie de Hodgkin, et la raison pour laquelle le financement est essentiel. Pour plusieurs, il s\u2019agit de leur dernier espoir; il est difficile d\u2019accepter que la vie ou la mort d\u2019un patient repose sur une question de financement.<\/p>\n","protected":false},"excerpt":{"rendered":"

En f\u00e9vrier dernier, Sant\u00e9 Canada a autoris\u00e9 la vente d\u2019ADCETRIS,<\/p>\n","protected":false},"author":1,"featured_media":1829,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[10],"tags":[],"class_list":{"0":"post-1832","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-nouvelles"},"acf":[],"yoast_head":"\nLe prix fort d\u2019un traitement innovant - Lymphoma Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Le prix fort d\u2019un traitement innovant - Lymphoma Canada\" \/>\n<meta property=\"og:description\" content=\"En f\u00e9vrier dernier, Sant\u00e9 Canada a autoris\u00e9 la vente d\u2019ADCETRIS,\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/\" \/>\n<meta property=\"og:site_name\" content=\"Lymphoma Canada\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LymphomaCanada\" \/>\n<meta property=\"article:published_time\" content=\"2013-05-08T13:49:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/05\/adcetris_pack.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@lymphomacanada\" \/>\n<meta name=\"twitter:site\" content=\"@lymphomacanada\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4\"},\"headline\":\"Le prix fort d\u2019un traitement innovant\",\"datePublished\":\"2013-05-08T13:49:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/\"},\"wordCount\":579,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/05\/adcetris_pack.jpg\",\"articleSection\":[\"Nouvelles\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/\",\"name\":\"Le prix fort d\u2019un traitement innovant - Lymphoma Canada\",\"isPartOf\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/05\/adcetris_pack.jpg\",\"datePublished\":\"2013-05-08T13:49:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/#primaryimage\",\"url\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/05\/adcetris_pack.jpg\",\"contentUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/05\/adcetris_pack.jpg\",\"width\":700,\"height\":300,\"caption\":\"adcetris_pack\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.lymphoma.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Le prix fort d\u2019un traitement innovant\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#website\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/\",\"name\":\"Lymphoma Canada\",\"description\":\"Information. Help. Hope.\",\"publisher\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lymphoma.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#organization\",\"name\":\"Lymphoma Canada\",\"url\":\"https:\/\/www.lymphoma.ca\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg\",\"contentUrl\":\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg\",\"width\":343,\"height\":343,\"caption\":\"Lymphoma Canada\"},\"image\":{\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/LymphomaCanada\",\"https:\/\/x.com\/lymphomacanada\",\"https:\/\/www.linkedin.com\/company\/lymphoma-canada\/\",\"http:\/\/instagram.com\/lymphomacanada\",\"http:\/\/www.youtube.com\/user\/LymphomaTV\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/www.lymphoma.ca\/fr\/author\/erezz_oxmaxp0p\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Le prix fort d\u2019un traitement innovant - Lymphoma Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/","og_locale":"fr_FR","og_type":"article","og_title":"Le prix fort d\u2019un traitement innovant - Lymphoma Canada","og_description":"En f\u00e9vrier dernier, Sant\u00e9 Canada a autoris\u00e9 la vente d\u2019ADCETRIS,","og_url":"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/","og_site_name":"Lymphoma Canada","article_publisher":"https:\/\/www.facebook.com\/LymphomaCanada","article_published_time":"2013-05-08T13:49:09+00:00","og_image":[{"width":700,"height":300,"url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/05\/adcetris_pack.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@lymphomacanada","twitter_site":"@lymphomacanada","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/#article","isPartOf":{"@id":"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/"},"author":{"name":"admin","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4"},"headline":"Le prix fort d\u2019un traitement innovant","datePublished":"2013-05-08T13:49:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/"},"wordCount":579,"commentCount":0,"publisher":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#organization"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/05\/adcetris_pack.jpg","articleSection":["Nouvelles"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/","url":"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/","name":"Le prix fort d\u2019un traitement innovant - Lymphoma Canada","isPartOf":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/#primaryimage"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/05\/adcetris_pack.jpg","datePublished":"2013-05-08T13:49:09+00:00","breadcrumb":{"@id":"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/#primaryimage","url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/05\/adcetris_pack.jpg","contentUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2013\/05\/adcetris_pack.jpg","width":700,"height":300,"caption":"adcetris_pack"},{"@type":"BreadcrumbList","@id":"https:\/\/www.lymphoma.ca\/fr\/le-prix-fort-dun-traitement-innovant\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.lymphoma.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Le prix fort d\u2019un traitement innovant"}]},{"@type":"WebSite","@id":"https:\/\/www.lymphoma.ca\/fr\/#website","url":"https:\/\/www.lymphoma.ca\/fr\/","name":"Lymphoma Canada","description":"Information. Help. Hope.","publisher":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lymphoma.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.lymphoma.ca\/fr\/#organization","name":"Lymphoma Canada","url":"https:\/\/www.lymphoma.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg","contentUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg","width":343,"height":343,"caption":"Lymphoma Canada"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LymphomaCanada","https:\/\/x.com\/lymphomacanada","https:\/\/www.linkedin.com\/company\/lymphoma-canada\/","http:\/\/instagram.com\/lymphomacanada","http:\/\/www.youtube.com\/user\/LymphomaTV"]},{"@type":"Person","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/3f654528f96ee33030061e70192633c4","name":"admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f8f0e240f88d3162ad64d22cede41425?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/www.lymphoma.ca\/fr\/author\/erezz_oxmaxp0p\/"}]}},"_links":{"self":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/1832","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/comments?post=1832"}],"version-history":[{"count":0,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/1832\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/media\/1829"}],"wp:attachment":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/media?parent=1832"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/categories?post=1832"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/tags?post=1832"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}